Aptevo Therapeutics Inc. (APVO) Net margin 2016–2023
Aptevo Therapeutics Inc. (APVO) net profit margin by fiscal year — reported net income divided by reported revenue.
-559.1%FY2023 · since FY2016: -334.6% → -559.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -559.1% | -624.4 pp |
| FY2022 | 65.3% | +725.7 pp |
| FY2021 | -660.4% | -605.7 pp |
| FY2020 | -54.7% | +120.6 pp |
| FY2019 | -175.4% | +190.9 pp |
| FY2018 | -366.3% | -436.1 pp |
| FY2017 | 69.8% | +404.4 pp |
| FY2016 | -334.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice